# LAPTM4A

## Overview
LAPTM4A is a gene that encodes the lysosomal protein transmembrane 4 alpha, a multi-pass transmembrane protein primarily localized in lysosomes and late endosomes. This protein is involved in various cellular processes, including glycolipid biosynthesis and cellular transport. It interacts with key enzymes and transporters, such as Gb3 synthase and the human organic cation transporter 2 (hOCT2), influencing their activity and localization (Grabner2011LAPTM4A; Yamaji2019A). LAPTM4A's role in these pathways is critical for maintaining cellular homeostasis and metabolic regulation. Clinically, LAPTM4A has been identified as a significant biomarker in gliomas, where its expression correlates with poor prognosis and influences immune response and cancer progression (Ding2024Identification).

## Structure
LAPTM4A is a multi-pass membrane protein characterized by four transmembrane domains, which contribute to its secondary structure (Grabner2011LAPTM4A; Yamaji2019A). The protein has cytoplasmic N and C termini, with the C-terminal region containing PY motifs that facilitate binding to the ubiquitin ligase NEDD4, a feature important for its lysosomal localization (Yamaji2019A). 

LAPTM4A is primarily localized in lysosomes and late endosomes, but it can also be found in the Golgi apparatus, suggesting a potential role in these cellular compartments (Tian2018Genomewide; Yamaji2019A). The protein interacts with Gb3 synthase, indicating a specific interaction that may influence glycolipid biosynthesis (Yamaji2019A). 

The second luminal domain of LAPTM4A is critical for its interaction with A4GALT, a Golgi-localized enzyme, and is responsible for the functional differences between LAPTM4A and its homolog LAPTM4B (Tian2018Genomewide). This domain may influence the catalytic activity or specificity of A4GALT, although the exact mechanism remains unclear (Tian2018Genomewide). 

Post-translational modifications, such as phosphorylation, may affect LAPTM4A's function and localization, although specific details are not provided in the context (Grabner2011LAPTM4A).

## Function
LAPTM4A is a protein involved in the regulation of glycolipid biosynthesis, particularly in the conversion of lactosylceramide (LacCer) to globotriaosylceramide (Gb3), a process catalyzed by Gb3 synthase. This protein interacts with Gb3 synthase, influencing its activity and stability, which is crucial for maintaining proper glycolipid levels in cells (Yamaji2019A). LAPTM4A is primarily localized to lysosomes and late endosomes, but it also partially localizes to the Golgi apparatus, where it interacts with Gb3 synthase, suggesting a role in the Golgi-related processes (Yamaji2019A).

In addition to its role in glycolipid biosynthesis, LAPTM4A interacts with the human organic cation transporter 2 (hOCT2), regulating its endocytotic recruitment and surface expression. This interaction affects the transport of organic cations in kidney cells, highlighting LAPTM4A's role in cellular transport processes (Grabner2011LAPTM4A). The protein's involvement in these molecular processes underscores its importance in maintaining cellular homeostasis and metabolic regulation. LAPTM4A's function in these pathways is essential for proper cellular function and organismal health, as it influences both glycolipid biosynthesis and the transport of organic molecules.

## Clinical Significance
LAPTM4A has been identified as a significant biomarker in gliomas, a type of brain cancer. Its expression is notably increased in low-grade glioma (LGG) and glioblastoma multiforme (GBM), correlating with poor prognosis, including reduced overall survival, disease-specific survival, and progression-free intervals in patients. High LAPTM4A expression is associated with advanced WHO grades, IDH wild-type status, and 1p19q non-co-deletion, indicating its role in glioma progression and severity (Ding2024Identification).

The gene's overexpression is linked to immune cell infiltration and immune checkpoint gene expressions, which can suppress T-cell activity and promote cancer development. This suggests that LAPTM4A may impact the effectiveness of immunotherapy in glioma patients (Ding2024Identification). Additionally, LAPTM4A is involved in the epithelial-mesenchymal transition (EMT) pathway, influencing glioma invasion and migration (Ding2024Identification).

In the context of glycolipid regulation, LAPTM4A plays a role in the biosynthesis of Gb3, a glycosphingolipid. Mutations or knockouts of LAPTM4A can lead to resistance to Shiga toxin-induced cell death, highlighting its importance in maintaining normal Gb3 levels and sensitivity to toxins (Yamaji2019A).

## Interactions
LAPTM4A interacts with several proteins, playing a significant role in cellular transport and lysosomal trafficking. It binds to the E3 ubiquitin ligase Nedd4-1 through its C-terminal PY motifs, which is crucial for its sorting to lysosomes. This interaction is necessary for the transport of LAPTM4A from the Golgi to late endosomes and lysosomes, although the PY motifs and Nedd4-1 are not strictly required for LAPTM4A ubiquitination (Hirota2021LAPTM4α). 

LAPTM4A also interacts with the human organic cation transporter 2 (hOCT2), influencing its endocytotic recruitment and surface expression. This interaction was confirmed through various assays, including FRET microscopy and immunofluorescence, showing colocalization in lysosomes and late endosomes. Overexpression of LAPTM4A reduces hOCT2 plasma membrane expression, suggesting a regulatory role in hOCT2-mediated transport (Grabner2011LAPTM4A).

Additionally, LAPTM4A interacts with Gb3 synthase, a key enzyme in glycolipid biosynthesis. This interaction is crucial for regulating Gb3 biosynthesis, although lysosomal localization is not essential for this function (Yamaji2019A). These interactions highlight LAPTM4A's role in cellular transport and regulatory processes.


## References


[1. (Hirota2021LAPTM4α) Yuko Hirota, Masaharu Hayashi, Yuu Miyauchi, Yuji Ishii, Yoshitaka Tanaka, and Keiko Fujimoto. Laptm4α is targeted from the golgi to late endosomes/lysosomes in a manner dependent on the e3 ubiquitin ligase nedd4-1 and escrt proteins. Biochemical and Biophysical Research Communications, 556:9–15, June 2021. URL: http://dx.doi.org/10.1016/j.bbrc.2021.03.151, doi:10.1016/j.bbrc.2021.03.151. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2021.03.151)

[2. (Ding2024Identification) Yongqi Ding, Yike Jiang, Hong Zeng, Minqin Zhou, Xuanrui Zhou, Zichuan Yu, Jingying Pan, Xitong Geng, Yanting Zhu, Hao Zheng, Shuhan Huang, Yiyang Gong, Huabin Huang, Chengfeng Xiong, and Da Huang. Identification of a robust biomarker laptm4a for glioma based on comprehensive computational biology and experimental verification. Aging, April 2024. URL: http://dx.doi.org/10.18632/aging.205736, doi:10.18632/aging.205736. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.205736)

[3. (Yamaji2019A) Toshiyuki Yamaji, Tsuyoshi Sekizuka, Yuriko Tachida, Chisato Sakuma, Kanta Morimoto, Makoto Kuroda, and Kentaro Hanada. A crispr screen identifies laptm4a and tm9sf proteins as glycolipid-regulating factors. iScience, 11:409–424, January 2019. URL: http://dx.doi.org/10.1016/j.isci.2018.12.039, doi:10.1016/j.isci.2018.12.039. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.isci.2018.12.039)

[4. (Tian2018Genomewide) Songhai Tian, Khaja Muneeruddin, Mei Yuk Choi, Liang Tao, Robiul H. Bhuiyan, Yuhsuke Ohmi, Keiko Furukawa, Koichi Furukawa, Sebastian Boland, Scott A. Shaffer, Rosalyn M. Adam, and Min Dong. Genome-wide crispr screens for shiga toxins and ricin reveal golgi proteins critical for glycosylation. PLOS Biology, 16(11):e2006951, November 2018. URL: http://dx.doi.org/10.1371/journal.pbio.2006951, doi:10.1371/journal.pbio.2006951. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.2006951)

[5. (Grabner2011LAPTM4A) A. Grabner, S. Brast, S. Sucic, S. Bierer, B. Hirsch, H. Pavenstädt, H. H. Sitte, E. Schlatter, and G. Ciarimboli. Laptm4a interacts with hoct2 and regulates its endocytotic recruitment. Cellular and Molecular Life Sciences, 68(24):4079–4090, May 2011. URL: http://dx.doi.org/10.1007/s00018-011-0694-6, doi:10.1007/s00018-011-0694-6. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-011-0694-6)